Insider Selling: HCA Healthcare (NYSE:HCA) SVP Sells 8,020 Shares of Stock
by Kim Johansen · The Markets DailyHCA Healthcare, Inc. (NYSE:HCA – Get Free Report) SVP Jennifer Berres sold 8,020 shares of the stock in a transaction that occurred on Wednesday, February 11th. The shares were sold at an average price of $514.58, for a total transaction of $4,126,931.60. Following the completion of the transaction, the senior vice president owned 11,993 shares of the company’s stock, valued at $6,171,357.94. This trade represents a 40.07% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
HCA Healthcare Stock Up 0.7%
NYSE HCA traded up $3.77 on Thursday, reaching $535.24. 1,657,111 shares of the stock traded hands, compared to its average volume of 1,179,844. HCA Healthcare, Inc. has a 12 month low of $295.00 and a 12 month high of $552.90. The firm’s fifty day simple moving average is $480.78 and its 200 day simple moving average is $446.23. The company has a market cap of $119.69 billion, a price-to-earnings ratio of 18.86, a P/E/G ratio of 1.63 and a beta of 1.36.
HCA Healthcare (NYSE:HCA – Get Free Report) last announced its earnings results on Tuesday, January 27th. The company reported $8.01 earnings per share for the quarter, beating the consensus estimate of $7.37 by $0.64. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.The business had revenue of $19.51 billion during the quarter, compared to analysts’ expectations of $19.67 billion. During the same quarter last year, the business posted $6.22 earnings per share. The company’s quarterly revenue was up 6.7% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, equities research analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.
HCA Healthcare Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Tuesday, March 17th will be given a $0.78 dividend. This represents a $3.12 annualized dividend and a yield of 0.6%. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.72. The ex-dividend date is Tuesday, March 17th. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.15%.
Wall Street Analyst Weigh In
Several equities research analysts have recently commented on HCA shares. Wells Fargo & Company upped their target price on HCA Healthcare from $452.00 to $481.00 and gave the company an “equal weight” rating in a report on Friday, January 30th. Morgan Stanley cut shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and set a $425.00 target price for the company. in a report on Monday, December 15th. Bank of America upped their price target on shares of HCA Healthcare from $430.00 to $470.00 and gave the company a “neutral” rating in a research report on Monday, October 27th. Mizuho set a $540.00 target price on HCA Healthcare in a report on Monday, February 2nd. Finally, Zacks Research lowered HCA Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Thursday, November 27th. Sixteen investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $523.27.
Get Our Latest Report on HCA Healthcare
More HCA Healthcare News
Here are the key news stories impacting HCA Healthcare this week:
- Positive Sentiment: Zacks Research raised FY-2026 EPS to $29.31 (from $28.47) and lifted multiple quarterly and multi‑year estimates (FY2027 to $33.44, FY2028 to $37.67), aligning analyst expectations with HCA’s FY2026 guidance and suggesting stronger forward profitability. Zacks remains at a “Hold” rating, but the higher estimates support valuation and earnings momentum. Zacks estimate changes (MarketBeat)
- Neutral Sentiment: HCA’s StoneSprings Hospital Center is planning to convert a Chantilly deli site into a freestanding emergency room — a local expansion that could modestly increase patient volumes and admissions in that market over time. HCA StoneSprings freestanding ER
- Neutral Sentiment: HCA-related ASC real estate was sold, a move that can free capital or change lease/operating dynamics for ambulatory surgery centers; the net effect depends on deal terms and use of proceeds. HCA ASC real estate sold
- Neutral Sentiment: Executive moves: a former HCA Florida executive joined Memorial Health as COO and an HCA veteran was named COO at Memorial Health in Georgia — routine industry leadership turnover that may have limited near‑term impact on HCA’s financials but is notable for regional competitive dynamics and management talent flow. Former HCA exec joins Memorial Health (MSN) HCA veteran named COO (Becker’s)
Institutional Investors Weigh In On HCA Healthcare
Hedge funds and other institutional investors have recently made changes to their positions in the company. MJP Associates Inc. ADV increased its holdings in HCA Healthcare by 2.9% in the fourth quarter. MJP Associates Inc. ADV now owns 749 shares of the company’s stock worth $350,000 after buying an additional 21 shares during the last quarter. Cary Street Partners Investment Advisory LLC raised its holdings in shares of HCA Healthcare by 7.5% during the 4th quarter. Cary Street Partners Investment Advisory LLC now owns 300 shares of the company’s stock valued at $140,000 after purchasing an additional 21 shares in the last quarter. Sovran Advisors LLC boosted its holdings in HCA Healthcare by 1.0% in the third quarter. Sovran Advisors LLC now owns 2,278 shares of the company’s stock worth $1,063,000 after purchasing an additional 22 shares in the last quarter. Centerpoint Advisors LLC lifted its position in shares of HCA Healthcare by 11.0% in the third quarter. Centerpoint Advisors LLC now owns 222 shares of the company’s stock worth $95,000 after buying an additional 22 shares during the last quarter. Finally, Cary Street Partners Financial LLC increased its holdings in shares of HCA Healthcare by 3.9% during the 3rd quarter. Cary Street Partners Financial LLC now owns 590 shares of the company’s stock valued at $251,000 after acquiring an additional 22 shares during the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.
HCA Healthcare Company Profile
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.